INTRODUCTION: African-American women are more likely than white women to have functional impairments after breast cancer (BC) surgery; however, no differences were found in self-reported health status surveys at 12+ months postsurgery. PURPOSE: This analysis compared white and African-American BC survivors' (BCS) health status, health-related quality of life, and the occurrence of physical impairments after BC treatment. METHODS: One hundred sixty-six women (130 white, 28 African-American, 8 other) were assessed for impairments preoperatively and at 1, 3, 6, 9, and 12+ months postsurgery. Health status was assessed at 12+ months using the Short Form Health Survey (SF36v2™). Analysis of variance estimated differences between groups for health status and impairment occurrence. RESULTS: No differences were found between groups for BC type, stage, grade, or tumor size; surgery type; or number of lymph nodes sampled. African-American BCS had more estrogen/progesterone receptor-negative tumors (p < 0.001; p = 0.036) and received radiation more frequently (p = 0.03). More African-American BCS were employed (p = 0.022) and reported higher rates of social activities (p = 0.011) but less recreational activities (p = 0.020) than white BCS. African-American BCS had higher rates of cording (p = 0.013) and lymphedema (p = 0.011) postoperatively. No differences were found in self-reported health status. CONCLUSION: In a military healthcare system, where access to care is ubiquitous, there were no significant differences in many BC characteristics commonly attributed to race. African-American women had more ER/PR-negative tumors; however, no other BC characteristics differed between racial groups. African-American women exhibited more physical impairments, although their BC treatment only differed regarding radiation therapy. This suggests that African-American BCS may be at higher risk for physical impairments and should be monitored prospectively for early identification and treatment.
INTRODUCTION: African-American women are more likely than white women to have functional impairments after breast cancer (BC) surgery; however, no differences were found in self-reported health status surveys at 12+ months postsurgery. PURPOSE: This analysis compared white and African-American BC survivors' (BCS) health status, health-related quality of life, and the occurrence of physical impairments after BC treatment. METHODS: One hundred sixty-six women (130 white, 28 African-American, 8 other) were assessed for impairments preoperatively and at 1, 3, 6, 9, and 12+ months postsurgery. Health status was assessed at 12+ months using the Short Form Health Survey (SF36v2™). Analysis of variance estimated differences between groups for health status and impairment occurrence. RESULTS: No differences were found between groups for BC type, stage, grade, or tumor size; surgery type; or number of lymph nodes sampled. African-American BCS had more estrogen/progesterone receptor-negative tumors (p < 0.001; p = 0.036) and received radiation more frequently (p = 0.03). More African-American BCS were employed (p = 0.022) and reported higher rates of social activities (p = 0.011) but less recreational activities (p = 0.020) than white BCS. African-American BCS had higher rates of cording (p = 0.013) and lymphedema (p = 0.011) postoperatively. No differences were found in self-reported health status. CONCLUSION: In a military healthcare system, where access to care is ubiquitous, there were no significant differences in many BC characteristics commonly attributed to race. African-American women had more ER/PR-negative tumors; however, no other BC characteristics differed between racial groups. African-American women exhibited more physical impairments, although their BC treatment only differed regarding radiation therapy. This suggests that African-American BCS may be at higher risk for physical impairments and should be monitored prospectively for early identification and treatment.
Authors: Janice N Cormier; Robert L Askew; Kristi S Mungovan; Yan Xing; Merrick I Ross; Jane M Armer Journal: Cancer Date: 2010-11-15 Impact factor: 6.860
Authors: Barbara A Springer; Ellen Levy; Charles McGarvey; Lucinda A Pfalzer; Nicole L Stout; Lynn H Gerber; Peter W Soballe; Jerome Danoff Journal: Breast Cancer Res Treat Date: 2010-02 Impact factor: 4.872
Authors: Nancy K Janz; Mahasin S Mujahid; Sarah T Hawley; Jennifer J Griggs; Amy Alderman; Ann S Hamilton; John Graff; Steven J Katz Journal: J Cancer Surviv Date: 2009-09-16 Impact factor: 4.442
Authors: Thomas F Hack; Winkle B Kwan; Roanne L Thomas-Maclean; Anna Towers; Baukje Miedema; Andrea Tilley; Dan Chateau Journal: Psychooncology Date: 2010-11 Impact factor: 3.894
Authors: Nicole L Stout Gergich; Lucinda A Pfalzer; Charles McGarvey; Barbara Springer; Lynn H Gerber; Peter Soballe Journal: Cancer Date: 2008-06-15 Impact factor: 6.860
Authors: Lorraine T Dean; Angela DeMichele; Mously LeBlanc; Alisa Stephens-Shields; Susan Q Li; Chris Colameco; Morgan Coursey; Jun J Mao Journal: Breast Cancer Res Treat Date: 2015-09-29 Impact factor: 4.872
Authors: Jean O'Toole; Cynthia L Miller; Michelle C Specht; Melissa N Skolny; Lauren S Jammallo; Nora Horick; Krista Elliott; Andrzej Niemierko; Alphonse G Taghian Journal: Breast Cancer Res Treat Date: 2013-06-29 Impact factor: 4.872
Authors: Kathleen M Sturgeon; Renata Hackley; Anna Fornash; Lorraine T Dean; Monica Laudermilk; Justin C Brown; David B Sarwer; Angela M DeMichele; Andrea B Troxel; Kathryn H Schmitz Journal: Cancer Date: 2017-09-07 Impact factor: 6.860